comprehensive -WSS

comprehensive

author：fashion 2025-10-02 19:38:41 - browse：58

Adam's take main illustration — Molly Ferguson/STAT

Behind the stellar commercial launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question: Does early success of the drug, called Relyvrio, make it more complicated, perhaps impossible, to pull it from the market if we find out next year that it doesn’t work?

On Monday night, Amylyx said Relyvrio sales totaled $22 million in 2022 — a period that covers slightly more than one calendar quarter given the drug’s U.S. approval last September. The company said approximately 1,300 ALS patients were on Relyvrio at the end of December, and it expects that number to at least double by the end of the first quarter.

“We’re probably going to double, closer to triple, our revenue in Q1,” said James Frates, Amylyx’s chief financial officer, speaking on Monday night’s conference call.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： My superpower is killing ticks

knowledge

WSS

What the cancer research community can learn from the Covid response

Neutralizing antibodies against HIV shows promise in children

Verily hires former Apple Health leader as chief scientific officer

What the cancer research community can learn from the Covid response

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Wikipedia

comprehensive

hotspot

Sports medicine is finally prioritizing gender equality

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Moonlake's readout produced a cash windfall. Risks remain

Microsoft strikes partnership with Duke Health to advance health AI

Alkermes shareholders re

For BCIs, commercial hurdles may be bigger than scientific ones

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

As demand for Covid shots wanes, Moderna seeks its next success

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

knowledge

OTC birth control: A brief history of over the counter pill design

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

A cyberattack has disrupted hospitals and health care in several states

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

How redistricting in 6 states could affect who controls Congress

'Ancient DNA,' 23andMe reveal African American ancestries

knowledge

knowledge

knowledge

knowledge